Literature DB >> 1700356

Interactions between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord.

David H Smullin1, Stephen R Skilling, Alice A Larson.   

Abstract

Using in vivo microdialysis in the dorsal spinal cord of the rat, we have previously observed increases in glutamate and aspartate during exposure to a noxious stimulus. The present investigation was designed to determine whether these increases may be mediated by substance P. Infusion of 1 mM of substance P in the dialysis fluid increased the concentrations of glutamate and aspartate, similar to the response seen during noxious stimulation. In addition, substance P also increased the concentrations of the inhibitory amino acids glycine and taurine. Calcitonin gene-related peptide, previously shown to enhance substance P-induced biting and scratching behavior, produced no effect on amino acid release by itself but potentiated the apparent release of taurine by substance P. To assess the importance of substance P-induced amino acid release in sensory processing, we examined the influence of taurine and of excitatory amino acid antagonists on the biting and scratching behavior produced by excitatory amino acids and substance P. Taurine selectively inhibited only substance P-induced biting and scratching while excitatory amino acid antagonists inhibited only excitatory amino acid-induced behavior. To further explore the ability of taurine to inhibit the substance P-induced behavior, 3 tests of nociception were then used. Pretreatment with taurine inhibited the nociceptive-related writhing behavior produced by an intraperitoneal injection of acetic acid in mice but failed to alter the latency of response in the hot plate or tail flick assay.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700356     DOI: 10.1016/0304-3959(90)91095-Z

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  16 in total

1.  Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis.

Authors:  D D Mitsikostas; M Sanchez del Rio; C Waeber; Z Huang; F M Cutrer; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus.

Authors:  H Liu; A M Mazarati; H Katsumori; R Sankar; C G Wasterlain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats.

Authors:  Araceli Diaz-Ruiz; Hermelinda Salgado-Ceballos; Sergio Montes; Valente Maldonado; Luis Tristan; Mireya Alcaraz-Zubeldia; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

Review 4.  The mechanisms of action of NSAIDs in analgesia.

Authors:  J N Cashman
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 5.  The role of excitatory amino acid receptors and intracellular messengers in persistent nociception after tissue injury in rats.

Authors:  T J Coderre
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

Review 6.  Neurotransmitters in subcortical somatosensory pathways.

Authors:  J Broman
Journal:  Anat Embryol (Berl)       Date:  1994-03

7.  The influence of glycine and related compounds on spinal cord injury-induced spasticity.

Authors:  R K Simpson; M Gondo; C S Robertson; J C Goodman
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

8.  GABA, glutamate and substance P-like immunoreactivity release: effects of novel GABAB antagonists.

Authors:  H Teoh; M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  c-fos and its Consequences in Pain.

Authors:  Asma Hayati Ahmad; Zalina Ismail
Journal:  Malays J Med Sci       Date:  2002-01

10.  [Intrathecal and epidural administration of non-opioid analgesics in acute and chronic pain treatment.].

Authors:  B Donner; M Tryba; M Zenz; M Strumpf
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.